Featured Post

Latest Gold News

Fed doves supporting gold Stronger rand crushing South African miners Economic power could shift further East with Hong Kong gold exch...

Tuesday, January 10, 2012

Merck (MRK) (KMR) (MRX) (MTB) (BYD) (GS) Downgraded

Merck & Co Inc. (NYSE: MRK), Kinder Morgan Management (NYSE: KMR), Medicis Pharmaceuticals (NYSE: MRX), M&T Bank Co. (NYSE: MTB), Boyd Gaming (NYSE: BYD) and Goldman Sachs (NYSE: GS) were downgraded by analysts.

Kinder Morgan Management (KMR) was downgraded by Tudor Pickering from an “Accumulate” rating to a “Hold” rating.

Merck & Co Inc. (MRK) was downgraded by Jefferies Group (NYSE:JEF) from a “Buy” rating to a “Hold” rating. They have a price target of $40.00 on the company, up from $37.00.

Medicis Pharmaceuticals (MRX) was downgraded by Canaccord Genuity from a “Buy” rating to a “Hold” rating. They have a price target of $36.00 on the company, down from $38.00.

M&T Bank Co. (MTB) was downgraded by Bank of America (NYSE:BAC) from a “Buy” rating to a “Neutral” rating.

Boyd Gaming (BYD) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from a “Neutral” rating to an “Underweight” rating. They have a price target of $5.00 on the company.

Goldman Sachs (GS) was downgraded by Wells Fargo & Co. (NYSE:WFC) from an “Outperform” rating to a “Market Perform” rating.

No comments: